Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("LEROUX-ROELS, Geert")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 41

  • Page / 2
Export

Selection :

  • and

Unmet needs in modern vaccinology Adjuvants to improve the immune responseLEROUX-ROELS, Geert.Vaccine. Supplement. 2010, Vol 28, Num 3, issn 1359-5938, C25-C36Article

Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigenDESOMBERE, Isabelle; WILLEMS, Annick; GIJBELS, Yvonne et al.Journal of virology. 2006, Vol 80, Num 7, pp 3506-3514, issn 0022-538X, 9 p.Article

Llama-Derived Single-Domain Intrabodies Inhibit Secretion of Hepatitis B Virions in MiceSERRUYS, Benedikte; VAN HOUTTE, Freya; VERBRUGGHE, Phebe et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 1, pp 39-49, issn 0270-9139, 11 p.Article

Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variantKAUL, Artur; WOERZ, Ilka; MEULEMAN, Philip et al.Journal of virology. 2007, Vol 81, Num 23, pp 13168-13179, issn 0022-538X, 12 p.Article

Comparative pre-clinical and clinical experience with oral polio vaccine produced on MRC-5 cells or on primary monkey kidney cellsPRIKAZSKY, Viktor; LEROUX-ROELS, Geert; VAN DAMME, Pierre et al.Vaccine. 2005, Vol 23, Num 33, pp 4219-4227, issn 0264-410X, 9 p.Article

Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicityVANLANDSCHOOT, Peter; VAN HOUTTE, Freya; HOEK, Frans et al.Journal of medical virology. 2003, Vol 70, Num 4, pp 513-519, issn 0146-6615, 7 p.Article

Production, characterization and in vitro testing of HBcAg-specific VHH intrabodiesSERRUYS, Benedikte; VAN HOUTTE, Freya; FARHOUDI-MOGHADAM, Ali et al.Journal of general virology. 2010, Vol 91, pp 643-652, issn 0022-1317, 10 p., 3Article

Evaluation of Cellular Immunity to Mumps in Vaccinated Individuals with or without Circulating Antibodies up to 16 Years after Their Last VaccinationVANDERMEULEN, Corinne; CLEMENT, Frédéric; ROELANTS, Mathieu et al.The Journal of infectious diseases. 2009, Vol 199, Num 10, pp 1457-1460, issn 0022-1899, 4 p.Article

Griffithsin Has Antiviral Activity against Hepatitis C VirusMEULEMAN, Philip; ALBECKA, Anna; BELOUZARD, Sandrine et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 5159-5167, issn 0066-4804, 9 p.Article

Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and ReplicationVASSILAKI, Niki; FRIEBE, Peter; MEULEMAN, Philipe et al.Journal of virology. 2008, Vol 82, Num 23, pp 11503-11515, issn 0022-538X, 13 p.Article

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimeraMEULEMAN, Philip; LIBBRECHT, Louis; DE VOS, Rita et al.Hepatology (Baltimore, Md.). 2005, Vol 41, Num 4, pp 847-856, issn 0270-9139, 10 p.Article

Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adultsVANDEPAPELIERE, Pierre; REHERMANN, Barbara; KOUTSOUKOS, Marguerite et al.Vaccine. 2005, Vol 23, Num 20, pp 2591-2601, issn 0264-410X, 11 p.Article

Polyfunctional CD4+ T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccineVAN BRAECKEL, Eva; DESOMBERE, Isabelle; CLEMENT, Frédéric et al.Vaccine. 2013, Vol 31, Num 36, pp 3739-3746, issn 0264-410X, 8 p.Article

Anti-CD81 Antibodies Can Prevent a Hepatitis C Virus Infection In VivoMEULEMAN, Philip; HESSELGESSER, Joseph; PAULSON, Matthew et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 6, pp 1761-1768, issn 0270-9139, 8 p.Article

Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis CDESOMBERE, Isabelle; VAN VLIERBERGHE, Hans; WEILAND, Ola et al.Journal of medical virology. 2007, Vol 79, Num 6, pp 701-713, issn 0146-6615, 13 p.Article

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virusMEULEMAN, Philip; LIBBRECHT, Louis; WIELAND, Stefan et al.Journal of virology. 2006, Vol 80, Num 6, pp 2797-2807, issn 0022-538X, 11 p.Article

Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvantDESOMBERE, Isabelle; VAN DER WIELEN, Marie; VAN DAMME, Pierre et al.Vaccine. 2002, Vol 20, Num 19-20, pp 2597-2602, issn 0264-410XArticle

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older AdultsLEROUX-ROELS, Isabel; LEROUX-ROELS, Geert; CLEMENT, Frédéric et al.The Journal of infectious diseases. 2012, Vol 206, Num 8, pp 1280-1290, issn 0022-1899, 11 p.Article

A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteersLEROUX-ROELS, Geert; DEPLA, Erik; HULSTAERT, Frank et al.Vaccine. 2004, Vol 22, Num 23-24, pp 3080-3086, issn 0264-410X, 7 p.Article

Seasonal influenza vaccine delivered by intradermal microinjection : A randomised controlled safety and immunogenicity trial in adultsLEROUX-ROELS, Isabel; VETS, Eva; FREESE, Ralf et al.Vaccine. 2008, Vol 26, Num 51, pp 6614-6619, issn 0264-410X, 6 p.Article

Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis CVAN VLIERBERGHE, Hans; DELANGHE, Joris R; DE BIE, Sylvia et al.European journal of gastroenterology & hepatology. 2001, Vol 13, Num 9, pp 1077-1081, issn 0954-691XArticle

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trialMCELHANEY, Janet E; BERAN, Jiri; DURAND, Christelle et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 6, pp 485-496, issn 1473-3099, 12 p.Article

A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In VivoMEULEMAN, Philip; CATANESE, Maria Teresa; LEROUX-ROELS, Geert et al.Hepatology (Baltimore, Md.). 2012, Vol 55, Num 2, pp 364-372, issn 0270-9139, 9 p.Article

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized miceLACEK, Krzysztof; VERCAUTEREN, Koen; LEROUX-ROELS, Geert et al.Journal of hepatology. 2012, Vol 57, Num 1, pp 17-23, issn 0168-8278, 7 p.Article

Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patientsVAN VLIERBERGHE, Hans; LANGLOIS, Michel; DELANGHE, Joris et al.Journal of hepatology. 2001, Vol 35, Num 6, pp 707-711, issn 0168-8278Article

  • Page / 2